ROSA DAVID A (CEO and President) reported 1 transaction at NEUROONE MEDICAL TECHNOLOGIES CORP
Review the transaction codes below to understand the nature of each event.
Filed: 2/4/2025ACC: 0001540354-25-000001
DirectorOfficer· CEO and President
Since Feb 2026
-2.24K
Net shares
Net seller
$2.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.24K
Price / share
$1.15
Trade value
$2.57K
% of position
0.2%
1/31/2025
1.14M→1.14M
Total
Net shares
−2.24K
Net value
-$2.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −2.24K | $1.15 | $2.57K | 0.2% | 1.14M | 1.14M |
| Total | −2.24K | -$2.57K | ||||||
Derivative Transactions0
No derivative transactions reported